Pfizer, Flynn appeal against UK regulator’s £89.4m fine for epilepsy drug price hike
Pfizer has been fined £84.2m and Flynn Pharma £5.2m after they increased prices by as much as 2,600% in September 2012. The companies have separately filed appeals in the Competition Appeal